|Grant Affiliation:||Haynes: Role of IgA in HIV-1 Protection|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-07-13|
|Study Made Public:||2016-01-15|
QC of IgA antibodies from RV144 vaccine recipient clonal memory B cell cultures
CAVD 375 is an immunogenicity study to isolate and evaluate IgA antibodies using specimens from vaccine recipients in the human clinical trial, RV144.
Sign in to see full information about this study and to download study data.